| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917829 | Radiotherapy and Oncology | 2016 | 9 Pages |
Abstract
This is the first independent proof for the feasibility of hypoxia gene expression signatures as a prognostic tool in HNSCC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bouchra Tawk, Christian Schwager, Oliver Deffaa, Gerhard Dyckhoff, Rolf Warta, Annett Linge, Mechthild Krause, Wilko Weichert, Michael Baumann, Christel Herold-Mende, Jürgen Debus, Amir Abdollahi,